Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Regeneration: Polyploid Cells Are the Key Drivers of Tumor Progression Publisher Pubmed



Moein S1, 2 ; Adibi R1, 2 ; Da Silva Meirelles L3 ; Nardi NB4 ; Gheisari Y2, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Regenerative Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. PPGBioSaude and School of Medicine, Lutheran University of Brazil, Av. Farroupilha 8001, Canoas, 92425-900, RS, Brazil
  4. 4. Institute of Cardiology of Rio Grande do Sul, Av Princesa Isabel 370, Porto Alegre, 90620-001, RS, Brazil
  5. 5. Gene Therapy Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Biochimica et Biophysica Acta - Reviews on Cancer Published:2020


Abstract

In spite of significant advancements of therapies for initial eradication of cancers, tumor relapse remains a major challenge. It is for a long time known that polyploid malignant cells are a main source of resistance against chemotherapy and irradiation. However, therapeutic approaches targeting these cells have not been appropriately pursued which could partly be due to the shortage of knowledge on the molecular biology of cell polyploidy. On the other hand, there is a rising trend to appreciate polyploid/ multinucleated cells as key players in tissue regeneration. In this review, we suggest an analogy between the functions of polyploid cells in normal and malignant tissues and discuss the idea that cell polyploidy is an evolutionary conserved source of tissue regeneration also exploited by cancers as a survival factor. In addition, polyploid cells are highlighted as a promising therapeutic target to overcome drug resistance and relapse. © 2020 Elsevier B.V.